Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
American Journal of Nephrology|September 6, 2012
Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injuryPrashant Jamadarkhana, Anita Chaudhary, Laxmikant Chhipa, et al.Neuropharmacology|December 21, 2010
Delayed intervention in experimental stroke with TRC051384--a small molecule HSP70 inducerAnookh Mohanan, Shailesh Deshpande, Prashant G Jamadarkhana, et al.International Journal of Hypertension|January 12, 2012
TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 RatsAnookh Mohanan, Ram Gupta, Amita Dubey, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 4, 2022
TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical TrialDeepa Joshi, Prashant Gj, Shohini Ghosh, et al.Frontiers in Pharmacology|October 4, 2021
Safety, Tolerability, and Pharmacokinetics of a Novel Mitochondrial Modulator, TRC150094, in Overweight and Obese Subjects: A Randomized Phase-I Clinical TrialDeepa Joshi, Prashant Jamadarkhana, Suchit Kumbhare, et al.Plos One|March 4, 2014
The effect of a diiodothyronine mimetic on insulin sensitivity in male cardiometabolic patients: a double-blind randomized controlled trialFleur van der Valk, Carlijne Hassing, Maartje Visser, et al.Pageof 1